Health Care
More on Health Care
Washington, DC (Mar. 21, 2019)— Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, and Rep.
Washington, D.C. (Mar. 6, 2019)—On Thursday, March 7, 2019, the Committee on Oversight and Reform will hold a hearing on "The Trump Administration's Response to the Drug Crisis."
WHERE: 2154 Rayburn House Office Building
WHEN: Thursday, March 7, 2019
TIME: 10:00 a.m.
PURPOSE
|
| Washington, D.C. (Feb. 1, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 12, 2019. The hearing will cover President Trump's first-ever National Drug Control Strategy, which the White House released yesterday. |
| Washington, D.C. (Jan. 28, 2019)—On Tuesday, January, 29, 2019, the Committee on Oversight and Reform will hold its first hearing of the 116th Congress on "Examining the Actions of Drug Companies in Raising Prescription Drug Prices." WHERE: 2154 Rayburn House Office Building WHEN: Tuesday, January 29, 2019 |
Washington, D.C. (Jan. 14, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, launched one of the most wide-ranging investigations in decades into the prescription drug industry's pricing practices.
Washington, D.C. (Jan. 10, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, announced the schedule for Committee hearings in January and February and issued the following statement:
Washington, D.C. (Jan. 9, 2019)—Today, Rep. Elijah E. Cummings, the Chairman of the Committee on Oversight and Reform, issued the following statement in response to a letter signed by more than 60 House Democrats asking the Democratic leadership to make addressing the opioid crisis a top priority for the 116th Congress: